AbCellera Biologics ABCL
$ 2.65
-0.94%
Quarterly report 2024-Q3
added 11-04-2024
AbCellera Biologics Income Statement 2011-2024 | ABCL
Annual Income Statement AbCellera Biologics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.53 B | 2.54 B | 2.4 B | 6 B | - | - | - | - | - | - | - | - | - |
Shares |
289 M | 285 M | 276 M | 159 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
5.28 | 8.91 | 8.71 | 37.7 | - | - | - | - | - | - | - | - | - |
Net Income |
-146 M | 159 M | 153 M | 119 M | -2.21 M | 309 K | - | - | - | - | - | - | - |
Revenue |
38 M | 485 M | 375 M | 233 M | 11.6 M | 8.83 M | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-237 M | 217 M | 204 M | 156 M | -4.12 M | - | - | - | - | - | - | - | - |
Interest Expense |
6.78 M | -4.04 M | -6.08 M | -6.81 M | -209 K | - | - | - | - | - | - | - | - |
EBITDA |
-213 M | 244 M | 219 M | 158 M | -738 K | 1.76 M | - | - | - | - | - | - | - |
Operating Expenses |
275 M | 269 M | 171 M | 77.1 M | 14 M | 7.99 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
61 M | 55.5 M | 41.8 M | 11.9 M | 2.75 M | 2.15 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement AbCellera Biologics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
295 M | 294 M | 293 M | 295 M | 289 M | 289 M | 288 M | 290 M | 285 M | 285 M | 284 M | 283 M | 279 M | 272 M | 270 M | 269 M | 153 M | 152 M | 152 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-51.1 M | -36.9 M | -40.6 M | - | -28.6 M | -30.5 M | -40.1 M | - | 26.6 M | -6.78 M | 169 M | - | -21.4 M | -2.32 M | 117 M | - | -2.69 M | 6.7 M | -2.09 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
6.51 M | 7.32 M | 9.95 M | - | 6.6 M | 10.1 M | 12.2 M | - | 101 M | 45.9 M | 317 M | - | 5.51 M | 27.6 M | 203 M | - | 9.36 M | 11.2 M | 4.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-93.7 M | -93.5 M | -54.9 M | - | -54.9 M | -51.4 M | -64.9 M | - | 37.7 M | -8.4 M | 225 M | - | -28.1 M | -7.03 M | 158 M | - | -1.77 M | -854 K | -2.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
17.9 M | 32.2 M | -1.53 M | - | 2.05 M | -1.97 M | 3.59 M | - | 1.15 M | -1.44 M | 665 K | - | -1.26 M | 314 K | 265 K | - | -2.26 M | -293 K | -1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-89.9 M | -90.1 M | -50 M | - | -51.8 M | -48.4 M | -59.4 M | - | 42.9 M | -3.51 M | 229 M | - | -24.4 M | -3.51 M | 161 M | - | -1.73 M | 39 K | -1.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
100 M | 101 M | 64.8 M | - | 61.5 M | 61.4 M | 77.1 M | - | 63.6 M | 54.3 M | 91.6 M | - | 33.6 M | 34.7 M | 44.7 M | - | 11.1 M | 12.1 M | 6.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
19.1 M | 20.2 M | 17.4 M | - | 14.4 M | 15.5 M | 15.1 M | - | 13.8 M | 14.4 M | 14.3 M | - | 11.3 M | 11.2 M | 6.42 M | - | 2.97 M | 1.5 M | 1.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency